ALTSTIEL LARRY DOUGLAS has filed 3 insider transactions across 1 company since October 2023.
Most recent transaction: a grant/award of 165000 shares of ProMIS Neurosciences Inc. ($PMN) on September 22, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sept. 22, 2025 | ProMIS Neurosciences Inc. | $PMN | ALTSTIEL LARRY DOUGLAS | Chief Medical Officer | A | Option (right to buy) | 165000 | $0.00 | 165,000.0000 | 34,851,203 | 9999.99% | 0.47% |
| Nov. 18, 2024 | ProMIS Neurosciences Inc. | $PMN | ALTSTIEL LARRY DOUGLAS | Chief Medical Officer | A | Option (right to buy) | 175000 | $0.00 | 175,000.0000 | 30,067,095 | 9999.99% | 0.58% |
| Oct. 26, 2023 | ProMIS Neurosciences Inc. | $PMN | ALTSTIEL LARRY DOUGLAS | Chief Medical Officer | A | Option (right to buy) | 12500 | $0.00 | 12,500.0000 | 12,370,830 | 9999.99% | 0.10% |